Introduction to Zhejiang Ceva Ebvac Biotech Co., Ltd.
Established in April 2005, Zhejiang Ceva Ebvac Biotech Co., Ltd. (previous Zhejiang Ebvac Biotech Co., Ltd.) is located at No. 401, 23rd Street, Hangzhou Economic and Technological Development Area, which was formerly known as Zhejiang Yibang Biotech Co., Ltd. It specializes in R&D, production, sales and technical services of animal vaccines and diagnostic reagents. Ceva Ebvac is a high-tech enterprise supported by the central government.
Since its establishment, Ceva Ebvac has been adhering to the core values of “Evolving for Better Vaccine”, leading the development through innovation, and adhering to scientific and technological innovation strategy. The company has also established strategic cooperative partnership with Harbin Veterinary Research Institute, CAAS, China Agricultural University, Zhejiang University, Nanjing Agricultural University and other scientific research institutions and institutions of higher learning; jointly established the VLP Technology Platform with Nova Biologiques lnc. and established the CAMBIVAC Biotechnology R&D Center with University of Cambridge. The company has been identified as Hangzhou High-tech Research and Development Center, Zhejiang High-tech Enterprise Research and Development Center and High-tech Enterprise Supported by the State. A number of technical know-how representing the world’s most advanced vaccine manufacturing technology has matured, including vaccine seed cloning and purification technology, cell cloning and purification technology, high copy virus vaccine antigen preparation technology, antigen refining concentration technique, antigen vitality stabilization technology, protein subunit vaccine development technology, temperature-sensitive gene mutation technology and so on. These technologies are fully applied to Ebvac products, so that the company can better meet various demands of users in product safety, effectiveness, purity, stabilization and other aspects.
The company currently has nine production lines including cytotoxic suspension culture inactivated vaccine production line, embryotoxic inactivated vaccine production line, embryotoxic live vaccine production line, cytotoxic live vaccine production line, and has more than 40 kinds of products including porcine circovirus inactivated vaccine, live mycoplasma hyopneumoniae vaccine, swine fever live vaccine, porcine pseudorabies live vaccine, combined inactivate vaccine of transmissible gastroenteritis of swine and porcine epizootic diarrhea, newcastle disease live vaccine (CS2 strain, La Sota strain), newcastle disease infectious bronchitis bivalent vaccine, duck plague, duck hepatitis and other high-quality products. During the 11 years, Ceva Ebvac has been growing steadily, and had a tenfold increase just for the sales of swine vaccine. After the name “Yibang” was changed into “Ebvac”, the company has achieved the target of 20% growth of annual sales income for 5 consecutive years from 2012 to 2016. In 2016 the annual sales income reached 140 million Yuan and the net profit reached 23 million Yuan.
On February 21, 2017, we ushered in the historic moment of Ceva Ebvac. In the presence of the Chinese Prime Minister and French Prime Minister, Zhejiang Ebvac Biotech Co., Ltd. and Ceva Santé Animale signed the joint-venture agreement successfully, and the company officially changed its name to “Zhejiang Ceva Ebvac Biotech Co., Ltd.” Ceva Ebvac will introduce the most advanced animal vaccine research and development, production technology and technical service model with the help of Ceva’s global technology and market platform, to build the world-class R&D Center that mainly focuses on swine vaccine development and create more competitive and innovative quality vaccines and service systems!
“International vision, local practice”! In the future development, Ceva Ebvac will promote the industrial upgrading driven by innovation, help with the construction of National bio-safety risk prevention and control system and secure the development of animal husbandry in China!
Together, beyond animal health!